Purpose: We previously demonstrated that intensity-modulated radiation therapy (IMRT)
significantly improves radiation dose distribution over three-dimensional planning for …

Introduction The relative rarity of mucosal melanomas of the head and neck (MMHN) has
made analysis of treatment approaches difficult. Advances in diagnostic techniques and …

BACKGROUND Malignant tumors of the skull base are rare. Therefore, no single center treats
enough patients to accumulate significant numbers for meaningful analysis of outcomes …

Purpose Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth
factor receptor. Cetuximab has activity in squamous cell carcinoma and enhances both …

Background. Advances in imaging, surgical technique, and perioperative care have made
craniofacial resection (CFR) an effective and safe option for treating malignant tumors …

Background: The Bethesda System for Reporting Thyroid Cytopathology is the standard for
interpreting fine needle aspiration (FNA) specimens. The “atypia of undetermined …

Objective To analyze voice function before and after thyroidectomy for patients with normal
preoperative voice using a standardized multidimensional voice assessment protocol. …

Background. Malignant tumors of the superior sinonasal vault are rare, and, because of this
and the varied histologic findings, most outcomes data reflect the experience of small patient …

18 F-FDG PET has a high accuracy in staging head and neck cancer, but its role in patients
with clinically and radiographically negative necks (N0) is less clear. In particular, the value …

For patients with locoregional advanced head and neck squamous cell carcinoma (HNSCC),
concurrent chemoradiotherapy is a widely accepted treatment, but the need for subsequent …